Found 4 hits for monomerid = 50469349 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase receptor UFO
(Homo sapiens (Human)) | BDBM50469349
(CHEMBL4281432)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1cccc(c1)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(4.25,-14.92,;5.58,-14.15,;6.91,-14.93,;8.25,-14.16,;8.25,-12.62,;9.58,-14.93,;10.91,-14.16,;10.92,-12.61,;12.24,-11.84,;13.58,-12.61,;15.06,-12.13,;15.97,-13.38,;15.06,-14.64,;15.8,-15.98,;17.34,-16,;18.08,-17.36,;17.28,-18.68,;18.03,-20.03,;15.74,-18.64,;15,-17.3,;13.58,-14.16,;12.25,-14.93,;15.77,-10.76,;14.94,-9.47,;15.65,-8.11,;17.2,-8.04,;18.02,-9.34,;17.31,-10.7,;19.56,-9.28,;20.38,-10.58,;21.91,-10.52,;22.63,-9.16,;24.17,-9.1,;21.81,-7.86,;20.27,-7.91,)| Show InChI InChI=1S/C28H40N6O/c1-4-6-20(2)30-28-29-18-25-26(19-34(27(25)31-28)22-9-11-24(35)12-10-22)21-7-5-8-23(17-21)33-15-13-32(3)14-16-33/h5,7-8,17-20,22,24,35H,4,6,9-16H2,1-3H3,(H,29,30,31)/t20-,22-,24-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50469349
(CHEMBL4281432)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1cccc(c1)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(4.25,-14.92,;5.58,-14.15,;6.91,-14.93,;8.25,-14.16,;8.25,-12.62,;9.58,-14.93,;10.91,-14.16,;10.92,-12.61,;12.24,-11.84,;13.58,-12.61,;15.06,-12.13,;15.97,-13.38,;15.06,-14.64,;15.8,-15.98,;17.34,-16,;18.08,-17.36,;17.28,-18.68,;18.03,-20.03,;15.74,-18.64,;15,-17.3,;13.58,-14.16,;12.25,-14.93,;15.77,-10.76,;14.94,-9.47,;15.65,-8.11,;17.2,-8.04,;18.02,-9.34,;17.31,-10.7,;19.56,-9.28,;20.38,-10.58,;21.91,-10.52,;22.63,-9.16,;24.17,-9.1,;21.81,-7.86,;20.27,-7.91,)| Show InChI InChI=1S/C28H40N6O/c1-4-6-20(2)30-28-29-18-25-26(19-34(27(25)31-28)22-9-11-24(35)12-10-22)21-7-5-8-23(17-21)33-15-13-32(3)14-16-33/h5,7-8,17-20,22,24,35H,4,6,9-16H2,1-3H3,(H,29,30,31)/t20-,22-,24-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 296 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of FLT3 (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Mer
(Homo sapiens (Human)) | BDBM50469349
(CHEMBL4281432)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1cccc(c1)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(4.25,-14.92,;5.58,-14.15,;6.91,-14.93,;8.25,-14.16,;8.25,-12.62,;9.58,-14.93,;10.91,-14.16,;10.92,-12.61,;12.24,-11.84,;13.58,-12.61,;15.06,-12.13,;15.97,-13.38,;15.06,-14.64,;15.8,-15.98,;17.34,-16,;18.08,-17.36,;17.28,-18.68,;18.03,-20.03,;15.74,-18.64,;15,-17.3,;13.58,-14.16,;12.25,-14.93,;15.77,-10.76,;14.94,-9.47,;15.65,-8.11,;17.2,-8.04,;18.02,-9.34,;17.31,-10.7,;19.56,-9.28,;20.38,-10.58,;21.91,-10.52,;22.63,-9.16,;24.17,-9.1,;21.81,-7.86,;20.27,-7.91,)| Show InChI InChI=1S/C28H40N6O/c1-4-6-20(2)30-28-29-18-25-26(19-34(27(25)31-28)22-9-11-24(35)12-10-22)21-7-5-8-23(17-21)33-15-13-32(3)14-16-33/h5,7-8,17-20,22,24,35H,4,6,9-16H2,1-3H3,(H,29,30,31)/t20-,22-,24-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase receptor TYRO3
(Homo sapiens (Human)) | BDBM50469349
(CHEMBL4281432)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1cccc(c1)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(4.25,-14.92,;5.58,-14.15,;6.91,-14.93,;8.25,-14.16,;8.25,-12.62,;9.58,-14.93,;10.91,-14.16,;10.92,-12.61,;12.24,-11.84,;13.58,-12.61,;15.06,-12.13,;15.97,-13.38,;15.06,-14.64,;15.8,-15.98,;17.34,-16,;18.08,-17.36,;17.28,-18.68,;18.03,-20.03,;15.74,-18.64,;15,-17.3,;13.58,-14.16,;12.25,-14.93,;15.77,-10.76,;14.94,-9.47,;15.65,-8.11,;17.2,-8.04,;18.02,-9.34,;17.31,-10.7,;19.56,-9.28,;20.38,-10.58,;21.91,-10.52,;22.63,-9.16,;24.17,-9.1,;21.81,-7.86,;20.27,-7.91,)| Show InChI InChI=1S/C28H40N6O/c1-4-6-20(2)30-28-29-18-25-26(19-34(27(25)31-28)22-9-11-24(35)12-10-22)21-7-5-8-23(17-21)33-15-13-32(3)14-16-33/h5,7-8,17-20,22,24,35H,4,6,9-16H2,1-3H3,(H,29,30,31)/t20-,22-,24-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of TYRO3 (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |